The Department of Health and Social Care is seeking views and any comments for those who may be affected or have a particular interest in the set up and functions of the new Patient Safety Commissioner for England.
The UK Government committed to establishing a Patient Safety Commissioner for England in the Medicines and Medical Devices Act 2021.
The introduction of a Patient Safety Commissioner also acts on the second recommendation of the Independent Medicines and Medical Devices Safety Review, First Do No Harm, published in July 2020 by Baroness Cumberlege, which examines the consequences of the use of Primodos, sodium valproate and pelvic mesh and its effects on patient safety.
The consultation process opened on the 10 June 2021 and closes on the 5 August 2021. It seeks views on a range of issues relating to the new Patient Safety Commissioner role, including:
- Terms of office
- Business Plan
- Annual Report
- Advisory Panel
- Conferring of functions on others
Responses will be considered and reviewed and will feed into the drafting of the secondary legislation for the Patient Safety Commissioner. A summary of responses, including the next steps, will be published after the consultation has closed.